Sanofi (SNY)
39.92
-0.75
(-1.84%)
USD |
NASDAQ |
Oct 02, 16:00
40.00
+0.08
(+0.20%)
After-Hours: 05:55
Sanofi Enterprise Value : 106.16B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 106.16B |
| October 01, 2026 | 107.98B |
| September 30, 2026 | 109.34B |
| September 29, 2026 | 108.15B |
| September 28, 2026 | 109.21B |
| September 25, 2026 | 109.05B |
| September 24, 2026 | 108.63B |
| September 23, 2026 | 110.38B |
| September 22, 2026 | 112.44B |
| September 21, 2026 | 112.42B |
| September 18, 2026 | 112.37B |
| September 17, 2026 | 113.97B |
| September 16, 2026 | 112.64B |
| September 15, 2026 | 112.18B |
| September 14, 2026 | 114.44B |
| September 11, 2026 | 113.08B |
| September 10, 2026 | 112.95B |
| September 09, 2026 | 113.27B |
| September 08, 2026 | 114.01B |
| September 04, 2026 | 116.65B |
| September 03, 2026 | 116.86B |
| September 02, 2026 | 117.20B |
| September 01, 2026 | 116.96B |
| August 31, 2026 | 116.94B |
| August 28, 2026 | 118.05B |
| Date | Value |
|---|---|
| August 27, 2026 | 118.10B |
| August 26, 2026 | 119.51B |
| August 25, 2026 | 120.97B |
| August 24, 2026 | 120.17B |
| August 21, 2026 | 120.55B |
| August 20, 2026 | 118.85B |
| August 19, 2026 | 120.51B |
| August 18, 2026 | 118.42B |
| August 17, 2026 | 117.06B |
| August 14, 2026 | 115.38B |
| August 13, 2026 | 115.53B |
| August 12, 2026 | 115.36B |
| August 11, 2026 | 114.99B |
| August 10, 2026 | 114.80B |
| August 07, 2026 | 114.75B |
| August 06, 2026 | 113.37B |
| August 05, 2026 | 113.10B |
| August 04, 2026 | 112.86B |
| August 03, 2026 | 113.51B |
| July 31, 2026 | 113.83B |
| July 30, 2026 | 113.37B |
| July 29, 2026 | 118.13B |
| July 28, 2026 | 119.80B |
| July 27, 2026 | 116.06B |
| July 24, 2026 | 114.48B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AstraZeneca PLC | 512.95B |
| GSK Plc | 114.59B |
| Johnson & Johnson | 644.86B |
| Eli Lilly & Co. | 1.122T |
| Merck & Co., Inc. | 403.00B |
Enterprise Value Related Metrics
| Earnings Yield | 4.86% |
| Operating Earnings Yield | 15.06% |
| Normalized Earnings Yield | 8.606 |